From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona’s bioscience industry is growing rapidly and reached nearly 30,000 jobs spanning 2,160 business establishments in 2018. Industry employment has grown by 15 percent since 2016—twice the growth rate of the nation—with each of the five major subsectors adding jobs during the period. Arizona’s universities conducted nearly $580 million in R&D activities in bioscience-related fields in 2018, fueled in part by steadily increasing NIH awards to Arizona institutions since 2016. Venture capital investments in Arizona bioscience companies increased in 2019, and during the 2016-19 period totaled $349 million. Arizona inventors have been awarded 2,178 bioscience-related patents since 2016, among the second quintile of states in patent activity.
IN THE LOOP
AZBio In The Loop is your opportunity to stay up to date on what is happening across Arizona's Life Science and Healthcare Community.
SubscribeAZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
Blood Cell Gene Expression can Predict Outcomes in Patients With Idiopathic Pulmonary Fibrosis (IPF), Study Finds
UA Senior Vice President for Health Sciences Dr. Joe G. N. “Skip” Garcia is co-senior author of a study published in Science Translational Medicine; results suggest that these potential biomarkers should be evaluated further for prioritizing lung transplantation and for drug studies.
Mission3 To Provide Thought Leadership and Expertise At DIA’s EDM and ERS/eCTD Conference
Phoenix, AZ – October 9, 2013 – Mission3, Inc., a Premier Regulatory Information Management provider for the Life Sciences industry, will be exhibiting at the DIA EDM and ERS/eCTD Conference in San Diego, CA during October 15-17. In addition, Dirk Beth, President and CEO of Mission3, and Adair Turner, Director of Professional Services at Mission3, […]
Longtime UA Cancer Center Director Dr. David S. Alberts Granted Director Emeritus Title
TUCSON, Ariz. – David S. Alberts, MD, director of the University of Arizona Cancer Center from 2005-2013, has been granted the director emeritus title by the Arizona Health Sciences Center.
Biodesign’s Nongjian (NJ) Tao wins prestigious 2013 Innovation Award
Nongjian (NJ) Tao is a winner of the Fourth Annual Innovation Award from Microscopy Today.